Grantee Wins Lemelson-MIT Prize
Dr. Robert S. Langer, an NIGMS grantee for 20 years, was recently awarded the 1998 Lemelson-MIT Prize -- the world's largest single prize for invention and innovation. He was honored for discoveries in controlled drug delivery and innovations in tissue engineering. He is a professor of biomedical and chemical engineering at Massachusetts Institute of Technology and a Harvard Medical School researcher at Children's Hospital Medical Center in Boston. In addition to codeveloping the first FDA-approved treatment for brain cancer in 20 years, Langer has done research that led to the development of artificial skin to treat burns and synthetic cartilage to treat joint injuries. The Lemelson-MIT Prize, established in 1994, is awarded annually for outstanding inventiveness and creativity that significantly benefit society. Langer received this year's award and its $500,000 prize at a ceremony at the Smithsonian Institution's National Museum of American History in Washington, D.C. He has also received support for shorter time periods from NEI, NIAID and NIAMS.
Up to Top